Fund Number: 5482 – Fund Title: PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)
Fund Number: 5482
Fund Title: PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)
Fund Category:
HIV/AIDS
Description:
NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited. There is a need to better understand the effects of substance use on PrEP effectiveness and better inform PrEP implementation among substance users. More systematic data are needed regarding the impact of substance use on PrEP management and adherence, along with investigating potential unintended consequences of PrEP use that may be unique to substance users such as changes in harm reduction practices, as well as substance use as a contributor to health risk behaviors with consequences such as increased occurrence of STIs.
Sponsor(s):
National Institutes of Health
National Institute on Drug Abuse
AIDS Research Program
Funder’s Fund ID: RFA-DA-20-013
Web Page: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-013.html
Application Due Date: 11/08/2019 November 8, 2019, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Award Date: 05/01/2020
Fund Duration: 5 years
Number of Awards: 3
Total Award: $2,000,000.00
Award Notes:
NIDA intends to commit $2,000,000 in FY 2020 to fund approximately 3 awards.
Eligible Locations:
– Not Applicable
Application Contact Name:
Edith Davis
Title: Financial/Grants Management Contact
Application Contact Address:
United States
Email: edavis1@mail.nih.gov
Phone: 301-827-6697
Technical Contact Name:
Richard A Jenkins PhD
Title: Scientific/Research Contact
Technical Contact Address:
United States
Email: jenkinsri@mail.nih.gov
Phone: 301-443-1923
Subject Areas:
– Clinical Trials
– Drug Abuse
– HIV
– HIV/AIDS Prevention
– Injecting Drug Use
– Substance Abuse Treatment and Counseling
Audiences:
– At Risk Persons
– Injecting Drug Users/Needle Sharing Partners
– Persons Practicing High Risk Behaviors
– Researchers
– State Government Agencies
– Substance Abusers
Eligibility:
– City Agencies
– Commercial Organizations
– Community Based Organizations
– County Agencies
– Health Care Service Organizations
– Nonprofit Organizations
– Public Health Departments/Social Services Departments
– State Agencies
Last Updated on June 18, 2019 by HepFree NYC
){kind=link}